Toll Free: 1-888-928-9744

Akers Biosciences, Inc. (AKER) - Product Pipeline Analysis, 2016 Update

Published: Jun 22, 2016 | Pages: 41 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Akers Biosciences, Inc. (ABI) is a medical device company that develops, manufactures and supplies in vitro diagnostic technologies. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone. ABI provides testing platform technologies that include MPC biosensor, particle immune-filtration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. It provides its products to healthcare facilities. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Akers Biosciences, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Akers Biosciences, Inc. Company Snapshot 6 Akers Biosciences, Inc. Company Overview 6 Akers Biosciences, Inc. Pipeline Products and Clinical Trials Overview 7 Akers Biosciences, Inc. - Pipeline Analysis Overview 9 Key Facts 9 Akers Biosciences, Inc. - Major Products and Services 10 Akers Biosciences, Inc. Pipeline Products by Development Stage 11 Akers Biosciences, Inc. Pipeline Products Overview 13 Breath PulmoHealth Check - Asthma 13 Breath PulmoHealth Check - Asthma Product Overview 13 Breath PulmoHealth Check - COPD 14 Breath PulmoHealth Check - COPD Product Overview 14 Breath PulmoHealth Check - Lung Cancer 15 Breath PulmoHealth Check - Lung Cancer Product Overview 15 Breath Test - Troponin I 16 Breath Test - Troponin I Product Overview 16 Diabetic Ketoacidosis Breath Test 17 Diabetic Ketoacidosis Breath Test Product Overview 17 Diagnostic Test - Heart Attack 18 Diagnostic Test - Heart Attack Product Overview 18 minDNAnalyzer 19 minDNAnalyzer Product Overview 19 PIFA Hepatitis C 20 PIFA Hepatitis C Product Overview 20 PIFA HIV 1+2 Rapid Assay 21 PIFA HIV 1+2 Rapid Assay Product Overview 21 PIFA PLUSS Chlamydia Rapid Assay 22 PIFA PLUSS Chlamydia Rapid Assay Product Overview 22 PIFA PLUSS Hepatitis B Assay 23 PIFA PLUSS Hepatitis B Assay Product Overview 23 PIFA PLUSS Malaria Rapid Assay 24 PIFA PLUSS Malaria Rapid Assay Product Overview 24 Akers Biosciences, Inc. - Key Competitors 25 Akers Biosciences, Inc. - Key Employees 26 Akers Biosciences, Inc. - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Recent Developments 28 Akers Biosciences, Inc., Recent Developments 28 May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016 28 May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016 30 Apr 29, 2016: Akers Board Rearrangement 32 Apr 25, 2016: Akers Biosciences: Board Rearrangement 33 Mar 30, 2016: Akers Biosciences Reports Earnings for Fiscal Year 2015 33 Mar 23, 2016: Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection 37 Mar 02, 2016: Akers Biosciences Announces $2.5M Order to Supply PIFA Heparin/PF4 Products to China 37 Feb 29, 2016: Akers Biosciences Hires Leading Commercial Executives to Support Sales Growth 38 Nov 23, 2015: Akers Biosciences Appoints Medical Technology Specialist as CEO 38 Nov 13, 2015: Akers Biosciences Announces Q3 2015 Earnings 39 Appendix 41 Methodology 41 About GlobalData 41 Contact Us 41 Disclaimer 41
List of Tables
Akers Biosciences, Inc. Pipeline Products and Clinical Trials Overview 7 Akers Biosciences, Inc. Pipeline Products by Equipment Type 7 Akers Biosciences, Inc. Pipeline Products by Indication 8 Akers Biosciences, Inc., Key Facts 9 Akers Biosciences, Inc., Major Products and Services 10 Akers Biosciences, Inc. Number of Pipeline Products by Development Stage 11 Akers Biosciences, Inc. Pipeline Products Summary by Development Stage 12 Breath PulmoHealth Check - Asthma - Product Status 13 Breath PulmoHealth Check - Asthma - Product Description 13 Breath PulmoHealth Check - COPD - Product Status 14 Breath PulmoHealth Check - COPD - Product Description 14 Breath PulmoHealth Check - Lung Cancer - Product Status 15 Breath PulmoHealth Check - Lung Cancer - Product Description 15 Breath Test - Troponin I - Product Status 16 Breath Test - Troponin I - Product Description 16 Diabetic Ketoacidosis Breath Test - Product Status 17 Diabetic Ketoacidosis Breath Test - Product Description 17 Diagnostic Test - Heart Attack - Product Status 18 Diagnostic Test - Heart Attack - Product Description 18 minDNAnalyzer - Product Status 19 minDNAnalyzer - Product Description 19 PIFA Hepatitis C - Product Status 20 PIFA Hepatitis C - Product Description 20 PIFA HIV 1+2 Rapid Assay - Product Status 21 PIFA HIV 1+2 Rapid Assay - Product Description 21 PIFA PLUSS Chlamydia Rapid Assay - Product Status 22 PIFA PLUSS Chlamydia Rapid Assay - Product Description 22 PIFA PLUSS Hepatitis B Assay - Product Status 23 PIFA PLUSS Hepatitis B Assay - Product Description 23 PIFA PLUSS Malaria Rapid Assay - Product Status 24 PIFA PLUSS Malaria Rapid Assay - Product Description 24 Akers Biosciences, Inc., Key Employees 26 Akers Biosciences, Inc., Subsidiaries 27


List of Figures
Akers Biosciences, Inc. Pipeline Products by Equipment Type 8 Akers Biosciences, Inc. Pipeline Products by Development Stage 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify